International Ophthalmology

, Volume 30, Issue 5, pp 539–552 | Cite as

Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis)

  • Ilknur Tugal-Tutkun
  • Carl P. Herbort
  • Moncef Khairallah
  • The Angiography Scoring for Uveitis Working Group (ASUWOG)
Original Paper


Purpose To propose a semiquantitative dual fluorescein angiography (FA) and indocyanine green angiography (ICGA) scoring system for uveitis that would assist in the follow-up of disease progression and monitoring response to treatment. Methods The scoring system was based on the FA scoring systems, the standardized ICGA protocol, and schematic interpretation of ICGA findings in posterior uveitis that have been previously published. We assigned scores to the fluorescein and ICG angiographic signs that represent ongoing inflammatory process in the posterior segment. We rated each angiographic sign according to the impact it has on our appreciation of active intraocular inflammation. In order to permit direct comparison between FA and ICGA, we multiplied the total ICGA score by a coefficient of 2 to adjust to the total score of FA. Results A total maximum score of 40 was assigned to the FA signs, including optic disc hyperfluorescence, macular edema, retinal vascular staining and/or leakage, capillary leakage, retinal capillary nonperfusion, neovascularization of the optic disc, neovascularization elsewhere, pinpoint leaks, and retinal staining and/or subretinal pooling. A total maximum score of 20 was assigned to the ICGA signs, including early stromal vessel hyperfluorescence, choroidal vasculitis, dark dots or areas (excluding atrophy), and optic disc hyperfluorescence. Conclusion The combined fluorescein and ICG angiographic scoring system proposed herein may help estimate the magnitude of retinal versus choroidal inflammation, monitor disease progression and response to treatment, and provide comparable data for clinical studies. The applicability of the proposed system needs to be tested in clinical settings, and intra- and interobserver variations need to be determined.


Uveitis Intraocular inflammation Fluorescein angiography Indocyanine green Angiography Angiographic scoring 


  1. 1.
    Ciardella AP, Borodoker N, Costa DL, Huang SJ, Cunningham ET Jr, Slakter JS (2002) Imaging the posterior segment in uveitis. Ophthalmol Clin North Am 15:281–296. doi: 10.1016/S0896-1549(02)00029-9 CrossRefPubMedGoogle Scholar
  2. 2.
    Ciardella AP, Prall FR, Borodoker N, Cunningham ET Jr (2004) Imaging techniques for posterior uveitis. Curr Opin Ophthalmol 15:519–530. doi: 10.1097/ CrossRefPubMedGoogle Scholar
  3. 3.
    Finamor LP, Muccioli C, Belfort R Jr (2005) Imaging techniques in the diagnosis and management of uveitis. Int Ophthalmol Clin 45:31–40. doi: 10.1097/01.iio.0000155937.05955.c2 CrossRefPubMedGoogle Scholar
  4. 4.
    Wolfensberger TJ, Herbort CP (1999) Indocyanine green angiographic features in ocular sarcoidosis. Ophthalmology 106:285–289. doi: 10.1016/S0161-6420(99)90067-2 CrossRefPubMedGoogle Scholar
  5. 5.
    Matsuo T, Itami M, Shiraga F (2000) Choroidopathy in patients with sarcoidosis observed by simultaneous indocyanine green and fluorescein angiography. Retina 20:16–21. doi: 10.1097/00006982-200001000-00003 CrossRefPubMedGoogle Scholar
  6. 6.
    Wolfensberger TJ, Piguet B, Herbort CP (1999) Indocyanine green angiographic features in tuberculous chorioretinitis. Am J Ophthalmol 127:350–353. doi: 10.1016/S0002-9394(98)00325-0 CrossRefPubMedGoogle Scholar
  7. 7.
    Mora P, Borruat FX, Guex-Crosier Y (2005) Indocyanine green angiography anomalies in ocular syphilis. Retina 25:171–181. doi: 10.1097/00006982-200502000-00010 CrossRefPubMedGoogle Scholar
  8. 8.
    Auer C, Bernasconi O, Herbort CP (1999) Indocyanine green angiography features in toxoplasmic retinochoroiditis. Retina 19:22–29. doi: 10.1097/00006982-199901000-00004 CrossRefPubMedGoogle Scholar
  9. 9.
    Atmaca LS, Simsek T, Atmaca Sonmez P, Sonmez K (2006) Fluorescein and indocyanine green angiography in ocular toxoplasmosis. Graefes Arch Clin Exp Ophthalmol 244:1688–1691. doi: 10.1007/s00417-006-0345-z CrossRefPubMedGoogle Scholar
  10. 10.
    Auer C, Bernasconi O, Herbort CP (1997) Toxoplasmic retinochoroiditis: new insights provided by indocyanine green angiography. Am J Ophthalmol 123:131–133PubMedGoogle Scholar
  11. 11.
    Bernasconi O, Auer C, Zografos L, Herbort CP (1998) Indocyanine green angiographic findings in sympathetic ophthalmia. Graefes Arch Clin Exp Ophthalmol 236:635–638. doi: 10.1007/s004170050134 CrossRefPubMedGoogle Scholar
  12. 12.
    Herbort CP, Mantovanni A, Bouchenaki N (2007) Indocyanine gren angiography in Vogt-Koyanagi-Harada disease:angiographic signs and utility in patient follow-up. Int Ophthalmol 27:173–182. doi: 10.1007/s10792-007-9060-y CrossRefPubMedGoogle Scholar
  13. 13.
    Cimino L, Auer C, Herbort CP (2000) Sensitivity of indocyanine green angiography for the follow-up of active inflammatory choriocapillaropathies. Ocul Immunol Inflamm 8:275–283. doi: 10.1076/ocii. CrossRefPubMedGoogle Scholar
  14. 14.
    Vadalà M, Lodato G, Cillino S (2001) Multifocal choroiditis: indocyanine green angiographic features. Ophthalmologica 215:16–21. doi: 10.1159/000050820 CrossRefPubMedGoogle Scholar
  15. 15.
    Slakter JS, Giovannini A, Yannuzzi LA, Scassellati-Sforzolini B, Guyer DR, Sorenson JA et al (1997) Indocyanine green angiography of multifocal choroiditis. Ophthalmology 104:1813–1819PubMedGoogle Scholar
  16. 16.
    Di Crecchio L, Parodi MB, Saviano S, Ravalico G (2001) Acute posterior multifocal placoid pigment epitheliopathy and ulcerative colitis: a possible association. Acta Ophthalmol Scand 79:319–321. doi: 10.1034/j.1600-0420.2001.790324.x CrossRefPubMedGoogle Scholar
  17. 17.
    Obana A, Kusumi M, Miki T (1996) Indocyanine green angiographic aspects of multiple evanescent white dot syndrome. Retina 16:97–104. doi: 10.1097/00006982-199616020-00002 CrossRefPubMedGoogle Scholar
  18. 18.
    Ie D, Glaser BM, Murphy RP, Gordon LW, Sjaarda RN, Thompson JT (1994) Indocyanine green angiography in multiple evanescent white-dot syndrome. Am J Ophthalmol 117:7–12PubMedGoogle Scholar
  19. 19.
    Stoffelns BM (2006) Long-term follow-up and angiographic findings in serpiginous choroiditis. Klin Monatsbl Augenheilkd 223:418–421. doi: 10.1055/s-2006-926575 CrossRefPubMedGoogle Scholar
  20. 20.
    Giovannini A, Mariotti C, Ripa E, Scassellati-Sforzolini B (1996) Indocyanine green angiographic findings in serpiginous choroidopathy. Br J Ophthalmol 80:536–540. doi: 10.1136/bjo.80.6.536 CrossRefPubMedGoogle Scholar
  21. 21.
    Fardeau C, Herbort CP, Kullmann N, Quentel G, LeHoang P (1999) Indocyanine green angiography in birdshot chorioretinopathy. Ophthalmology 106:1928–1934. doi: 10.1016/S0161-6420(99)90403-7 CrossRefPubMedGoogle Scholar
  22. 22.
    Gharbiya M, Pecci G, Baglio V, Gargiulo A, Allievi F, Balacco-Gabrieli C (2006) Indocyanine green angiographic findings for patients with systemic lupus erythematosus nephropathy. Retina 26:159–164. doi: 10.1097/00006982-200602000-00006 CrossRefPubMedGoogle Scholar
  23. 23.
    Dhingra S, Stavrou P (2004) Indocyanine green angiography in systemic lupus erythematosus-associated uveitis. Ocul Immunol Inflamm 12:69–73. doi: 10.1076/ocii. CrossRefPubMedGoogle Scholar
  24. 24.
    Gharbiya M, Bozzoni-Pantaleoni F, Augello F, Balacco-Gabrieli C (2002) Indocyanine green angiographic findings in systemic lupus erythematosus choroidopathy. Am J Ophthalmol 134:286–290. doi: 10.1016/S0002-9394(02)01477-0 CrossRefPubMedGoogle Scholar
  25. 25.
    Bouchenaki N, Cimino L, Auer C, Tao Tran V, Herbort CP (2002) Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography. Klin Monatsbl Augenheilkd 219:243–249. doi: 10.1055/s-2002-30661 CrossRefPubMedGoogle Scholar
  26. 26.
    Herbort CP, LeHoang P, Guex-Crosier Y (1998) Schematic interpretation of indocyanine gren angiography in posterior uveitis using a standard angiographic protocol. Ophthalmology 105:432–440. doi: 10.1016/S0161-6420(98)93024-X CrossRefPubMedGoogle Scholar
  27. 27.
    Altan-Yaycioglu R, Akova YA, Akca S, Yilmaz G (2006) Inflammation of the posterior uvea: findings on fundus fluorescein and indocyanine green angiography. Ocul Immunol Inflamm 14:171–179. doi: 10.1080/09273940600660524 CrossRefPubMedGoogle Scholar
  28. 28.
    Klaeger A, Tran AT, Hiroz CA, Morisod L, Herbort CP (2000) Indocyanine green angiography in Behçet’s uveitis. Retina 20:309–314PubMedGoogle Scholar
  29. 29.
    Bozzoni-Pantaleoni F, Gharbiya M, Pirraglia MP, Accorinti M, Pivetti-Pezzi P (2001) Indocyanine green angiographic findings in Behçet disease. Retina 21:230–236. doi: 10.1097/00006982-200106000-00006 CrossRefPubMedGoogle Scholar
  30. 30.
    Atmaca LS, Sonmez PA (2003) Fluorescein and indocyanine green angiography findings in Behçet’s disease. Br J Ophthalmol 87:1466–1468. doi: 10.1136/bjo.87.12.1466 CrossRefPubMedGoogle Scholar
  31. 31.
    Gedik S, Akova YA, Yilmaz G, Bozbeyoglu S (2005) Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behçet’s disease. Ocul Immunol Inflamm 13:51–58. doi: 10.1080/09273940490518757 CrossRefPubMedGoogle Scholar
  32. 32.
    Herbort CP, Probst K, Cimino L, Tran VT (2004) Differential inflammatory involvement in retina and choroïd in birdshot chorioretinopathy. Klin Monatsbl Augenheilkd 221:351–356. doi: 10.1055/s-2004-812827 CrossRefPubMedGoogle Scholar
  33. 33.
    BenEzra D, Forrester JV, Nussenblatt RB, Tabbara K, Timonen P (1991) Uveitis scoring system. Springer Verlag, BerlinGoogle Scholar
  34. 34.
    Suhler EB, Smith JR, Wertheim MS, Lauer AK, Kurz DE, Pickard TD et al (2005) A prospective trial of infliximab therapy for refractory uveitis. Preliminary safety and efficacy outcomes. Arch Ophthalmol 123:903–912. doi: 10.1001/archopht.123.7.903 CrossRefPubMedGoogle Scholar
  35. 35.
    Monnet D, Brezin AP, Holland GN, Yu F, Mahr A, Gordon LK et al (2006) Longitudinal cohort study of patients with birshot chorioretnopathy. I. Baseline clinical characteristics. Am J Ophthalmol 141:135–142. doi: 10.1016/j.ajo.2005.08.067 CrossRefPubMedGoogle Scholar
  36. 36.
    Monnet D, Levinson RD, Holland GN, Haddad L, Yu F, Brezin AP (2007) Longitudinal cohort study of patients with birdshot chorioretinopathy. II. Macular imaging at baseline. Am J Ophthalmol 144:818–828. doi: 10.1016/j.ajo.2007.08.011 CrossRefPubMedGoogle Scholar
  37. 37.
    Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140:509–516. doi: 10.1016/j.ajo.2005.01.035 CrossRefPubMedGoogle Scholar
  38. 38.
    Mandava N, Guyer DR, Yannuzzi LA, Nichol J, Orlock D (1999) Principles of fluorescein angiography. In: Guyer DR, Yannuzzi LA, Chang S, Shields JA, Green WR (eds) Retina–vitreous–macula, vol 1. WB Saunders, Philadelphia, pp 29–38Google Scholar
  39. 39.
    Van Kooij B, Fijnheer R, de Boer J, Dam-Van Loon NT, Bartelink I, Roest M et al (2006) A randomized, masked, cross-over trial of lisinopril for inflammatory macular edema. Am J Ophthalmol 141:451–646. doi: 10.1016/j.ajo.2005.11.056 Google Scholar
  40. 40.
    Lardenoye CW, van Schooneveld MJ, Frits TW, Rothova A (1998) Grid laser photocoagulation for macular edema in uveitis or the Irvine-Gass syndrome. Br J Ophthalmol 82:1013–1016CrossRefPubMedGoogle Scholar
  41. 41.
    Miyake K, Sakamura S, Miura H (1980) Long-term follow-up study on prevention of aphakic cystoid macular oedema by topical indomethacin. Br J Ophthalmol 64:324–328. doi: 10.1136/bjo.64.5.324 CrossRefPubMedGoogle Scholar
  42. 42.
    Spaide RF, Yannuzzi LA, Sisco LJ (1993) Chronic cystoid macular edema and predictors of visual acuity. Ophthalmic Surg 24:262–267PubMedGoogle Scholar
  43. 43.
    Antcliff RJ, Stanford MR, Chauhan DS, Graham EM, Spalton DJ, Shilling JS, Ffytche TJ, Marshall J (2000) Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology 107:593–599. doi: 10.1016/S0161-6420(99)00087-1 CrossRefPubMedGoogle Scholar
  44. 44.
    Whitcup SM, Csaky KG, Podgor MJ, Chew EY, Perry CH, Nussenblatt RB (1996) A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis. Ophthalmology 103:1054–1063PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Ilknur Tugal-Tutkun
    • 1
  • Carl P. Herbort
    • 2
  • Moncef Khairallah
    • 3
  • The Angiography Scoring for Uveitis Working Group (ASUWOG)
    • 4
  1. 1.Department of Ophthalmology, Istanbul Faculty of MedicineIstanbul UniversityIstanbulTurkey
  2. 2.Inflammatory Eye DiseasesCenter for Specialized Ophthalmic CareLausanneSwitzerland
  3. 3.Department of OphthalmologyFattouma Bourguiba University HospitalMonastirTunisia
  4. 4.LausanneSwitzerland

Personalised recommendations